| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Babbette LaMarca | Q88459247 |
| P2093 | author name string | Denise C Cornelius | |
| Lorena M Amaral | |||
| Mark W Cunningham | |||
| P2860 | cites work | The L-arginine-nitric oxide pathway | Q24304874 |
| L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species | Q44743355 | ||
| Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study | Q24597867 | ||
| A leading role for the immune system in the pathophysiology of preeclampsia | Q27003069 | ||
| Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function | Q27014799 | ||
| Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression | Q27022973 | ||
| Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond | Q27027039 | ||
| Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control study | Q28281936 | ||
| Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats | Q28571017 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association | Q30501645 | ||
| Peripheral arterial pulse wave analysis in women with pre-eclampsia and gestational hypertension | Q33225180 | ||
| Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases | Q33405115 | ||
| B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases | Q33407206 | ||
| Dietary L-arginine prevents fetal growth restriction in rats | Q33487400 | ||
| Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation | Q33490821 | ||
| Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy | Q33607465 | ||
| Fetal origins of coronary heart disease | Q33612387 | ||
| Single-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive management | Q33774671 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Exposure to AT1 receptor autoantibodies during pregnancy increases susceptibility of the maternal heart to postpartum ischemia-reperfusion injury in rats | Q34072217 | ||
| Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1 | Q34117998 | ||
| Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy | Q34182166 | ||
| Latest advances in understanding preeclampsia | Q34425288 | ||
| Developmental Origins of Cardiovascular Disease. | Q34429059 | ||
| Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy | Q34453242 | ||
| Maternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant women | Q34495512 | ||
| Endothelin-1 is not a Mechanism of IL-17 Induced Hypertension during Pregnancy. | Q34533218 | ||
| Neutrophil NETs: a novel contributor to preeclampsia-associated placental hypoxia? | Q34648192 | ||
| Recent Insights into the pathogenesis of pre-eclampsia | Q34682287 | ||
| Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. | Q34702420 | ||
| Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia | Q34997667 | ||
| Lymphocytes in atherosclerosis | Q35082438 | ||
| CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy | Q35130793 | ||
| Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease | Q35143007 | ||
| 17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model | Q35151065 | ||
| CD4+ T cells are important mediators of oxidative stress that cause hypertension in response to placental ischemia. | Q35153877 | ||
| Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation | Q45069619 | ||
| STAT6-dependent differentiation and production of IL-5 and IL-13 in murine NK2 cells | Q45094775 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Preeclampsia and the risk of end-stage renal disease | Q45748808 | ||
| Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization. | Q45947357 | ||
| Assessment of L-arginine asymmetric 1 dimethyl (ADMA) in early-onset and late-onset (severe) preeclampsia | Q46205723 | ||
| L-arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsia | Q46320346 | ||
| Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia | Q46332630 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
| Introducing a mouse model for pre-eclampsia: adoptive transfer of activated Th1 cells leads to pre-eclampsia-like symptoms exclusively in pregnant mice | Q46347472 | ||
| Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia | Q46433836 | ||
| The effects of IL-17 upon human natural killer cells. | Q46781991 | ||
| Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness | Q46841539 | ||
| Angiotensin II receptor type 1 autoantibodies promote endothelial microparticles formation through activating p38 MAPK pathway | Q46922047 | ||
| Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum | Q46983280 | ||
| Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood | Q47890265 | ||
| Plasma volume and glomerular filtration rate in pregnancy and their relation to differences in fetal growth. | Q47938222 | ||
| Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. | Q50514586 | ||
| Increased risk of rheumatoid arthritis in women with pregnancy complications and poor self-rated health: a study within the Danish National Birth Cohort. | Q50561211 | ||
| Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia. | Q51052391 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. | Q51359651 | ||
| Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. | Q51567875 | ||
| National cohort study of reproductive risk factors for rheumatoid arthritis in Denmark: a role for hyperemesis, gestational hypertension and pre-eclampsia? | Q51650308 | ||
| Differentiation of human NK cells into NK1 and NK2 subsets. | Q52036591 | ||
| Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. | Q52940276 | ||
| Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. | Q52981622 | ||
| Urinary podocyte excretion as a marker for preeclampsia. | Q53562117 | ||
| Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. | Q54112770 | ||
| Imbalance of T-cell transcription factors contributes to the Th1 type immunity predominant in pre-eclampsia. | Q54454734 | ||
| Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. | Q54587916 | ||
| Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. | Q54661322 | ||
| Peripheral arterial tone | Q56970588 | ||
| Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia | Q56981931 | ||
| Effects of L-arginine on utero-placental circulation in growth-retarded fetuses | Q60690409 | ||
| A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1 | Q61479346 | ||
| Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery | Q73258662 | ||
| Hypoxia stimulates cytokine production by villous explants from the human placenta | Q73320161 | ||
| Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia | Q73502640 | ||
| [Study of autoantibodies against the G-protein-coupled beta 2- and alpha 1-adrenergic and AT1 receptors in patients with primary hypertension] | Q73775849 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Pathophysiology of pregnancy-induced hypertension | Q74039094 | ||
| Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
| Increased nitric oxide synthase activity and expression in the human uterine artery during pregnancy | Q74253964 | ||
| Regulatory T cells mediate maternal tolerance to the fetus | Q75394803 | ||
| Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia | Q77908689 | ||
| Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia | Q78197149 | ||
| Exposure to experimental preeclampsia in mice enhances the vascular response to future injury | Q35175524 | ||
| Th1/Th2 balance in preeclampsia | Q35190885 | ||
| The discovery of nitric oxide and its role in vascular biology | Q35566587 | ||
| IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? | Q35581520 | ||
| AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsia | Q35689550 | ||
| Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia | Q35715914 | ||
| Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children | Q35882065 | ||
| L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats | Q35950303 | ||
| Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats | Q35994304 | ||
| Preeclampsia serum upregulates CD40/CD40L expression and induces apoptosis in human umbilical cord endothelial cells | Q36112505 | ||
| Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. | Q36115279 | ||
| A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model | Q36115311 | ||
| IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy | Q36178540 | ||
| Preeclampsia: recent insights | Q36288757 | ||
| Preeclampsia: current understanding of the molecular basis of vascular dysfunction | Q36378380 | ||
| The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy | Q36407259 | ||
| Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α. | Q36528002 | ||
| Mechanisms of disease: Pre-eclampsia | Q36577103 | ||
| Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats | Q36683260 | ||
| T cell regulation of natural killer cells | Q36907905 | ||
| Hypertension in pregnancy: an emerging risk factor for cardiovascular disease | Q36980294 | ||
| Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction | Q37022723 | ||
| The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia | Q37088970 | ||
| Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia | Q37229246 | ||
| Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension | Q37353499 | ||
| Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy | Q37353537 | ||
| Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy | Q37507162 | ||
| Preeclampsia: the role of angiogenic factors in its pathogenesis | Q37512886 | ||
| Regulatory T cells and inhibitory cytokines in autoimmunity | Q37621070 | ||
| Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy | Q37747554 | ||
| Changes of NK cells in preeclampsia | Q37987977 | ||
| Maternal fetal/placental interactions and abnormal pregnancy outcomes | Q79372322 | ||
| Placental imbalance of Th1- and Th2-type cytokines in preeclampsia | Q80387935 | ||
| Pre-eclampsia | Q81446389 | ||
| Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia | Q81508545 | ||
| Changes in cardiac structure and function in rats immunized by angiotensin type 1 receptor peptides | Q82259476 | ||
| eNOS haplotypes associated with gestational hypertension or preeclampsia | Q82298583 | ||
| Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(-) T-cells in decidua and maternal blood during human pregnancy | Q82406065 | ||
| Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia | Q83391804 | ||
| The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia | Q83523001 | ||
| Acute and transient podocyte loss and proteinuria in preeclampsia | Q83716971 | ||
| Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension | Q83799951 | ||
| The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25- FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia | Q83910661 | ||
| Increased circulating cell-free hemoglobin levels reduce nitric oxide bioavailability in preeclampsia | Q84324996 | ||
| eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension | Q84459697 | ||
| Origin, phenotype and function of human natural killer cells in pregnancy | Q84884086 | ||
| Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms | Q87175606 | ||
| B cell suppression in newborn following treatment of pregnant diffuse large B-cell lymphoma patient with rituximab containing regimen | Q87345443 | ||
| Angiotensin II type I receptor agonistic autoantibody-induced apoptosis in neonatal rat cardiomyocytes is dependent on the generation of tumor necrosis factor-α | Q95445011 | ||
| Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review | Q38012024 | ||
| Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies | Q38013891 | ||
| Fetomaternal immune cross-talk and its consequences for maternal and offspring's health | Q38104878 | ||
| Are monoclonal antibodies a safe treatment for cancer during pregnancy? | Q38119550 | ||
| Vascular dysfunction in preeclampsia | Q38124456 | ||
| Pre-eclampsia and future cardiovascular risk among women: a review | Q38194737 | ||
| Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth | Q38282115 | ||
| Molecular mechanisms of maternal vascular dysfunction in preeclampsia | Q38300968 | ||
| Long-term maternal atherosclerotic morbidity in women with pre-eclampsia | Q39063459 | ||
| Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension | Q39855290 | ||
| Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. | Q40463349 | ||
| Placental cytokines and the pathogenesis of preeclampsia | Q41452017 | ||
| Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus. | Q42274971 | ||
| 15 Million preterm births annually: what has changed this year? | Q42755401 | ||
| Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia | Q43008867 | ||
| Role of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia | Q43057030 | ||
| Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. | Q43576536 | ||
| Serum levels of IL-18, IL-12 and TH-1/TH-2 ratio in patients with pre-eclampsia | Q43585616 | ||
| HELLP syndrome in the 18th week of gestation in association with elevated angiotensin AT(1)-receptor autoantibodies | Q43672726 | ||
| Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction | Q43744794 | ||
| Angiotensin II-induced vascular dysfunction depends on interferon-γ-driven immune cell recruitment and mutual activation of monocytes and NK-cells. | Q44119832 | ||
| Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension | Q44162378 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Relationship between adiponectin and nitrite in healthy and preeclampsia pregnancies | Q44456656 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| maternal health | Q6786626 | ||
| pre-eclampsia | Q61335 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 403-15 | |
| P577 | publication date | 2015-07-15 | |
| P1433 | published in | Vascular Health and Risk Management | Q7916443 |
| P1476 | title | Preeclampsia: long-term consequences for vascular health | |
| P478 | volume | 11 |
| Q53700889 | AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats. |
| Q34541831 | Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy |
| Q40658001 | All-Cause and Cause-Specific Mortality After Hypertensive Disease of Pregnancy |
| Q89800074 | Analyzing Preeclampsia as the Tip of the Iceberg Represented by Women with Long-Term Cardiovascular Disease, Atherosclerosis, and Inflammation |
| Q55380827 | Are There Differences in the Anthropometric, Hemodynamic, Hematologic, and Biochemical Profiles between Late- and Early-Onset Preeclampsia? |
| Q36062345 | Association Between Gene Polymorphisms on Chromosome 1 and Susceptibility to Pre-Eclampsia: An Updated Meta-Analysis |
| Q36410470 | Case 6/2015 - 40-Year-Old Female with Acute Chest Pain, Dyspnea and Shock |
| Q49789815 | Ceramide-induced BOK promotes mitochondrial fission in preeclampsia |
| Q41110458 | Cystatin-C as a Marker for Renal Impairment in Preeclampsia. |
| Q58799364 | Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany |
| Q57819099 | Hypertension, Anxiety, and Blood-Brain Barrier Permeability Are Increased in Postpartum Severe Preeclampsia/Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome Rats |
| Q28078452 | Hypertensive disorders in pregnancy |
| Q90069958 | Lasting Effects of Intrauterine Exposure to Preeclampsia on Offspring and the Underlying Mechanism |
| Q37730499 | Long-term cerebral white and gray matter changes after preeclampsia |
| Q88631552 | Management of Obstructive Sleep Apnea in Pregnancy |
| Q91710578 | Mapping Modeled Exposure of Wildland Fire Smoke for Human Health Studies in California |
| Q93029168 | Maternal Death and Its Investigation |
| Q64108020 | Maternal Venous Hemodynamic Dysfunction in Proteinuric Gestational Hypertension: Evidence and Implications |
| Q86575810 | Maternal serum uric acid concentration is associated with the expression of tumour necrosis factor-α and intercellular adhesion molecule-1 in patients with preeclampsia |
| Q91962935 | Natural killer cells contribute to mitochondrial dysfunction in response to placental ischemia in reduced uterine perfusion pressure rats |
| Q60921565 | Pharmacological Effect of Quercetin in Hypertension and Its Potential Application in Pregnancy-Induced Hypertension: Review of , , and Clinical Studies |
| Q58605354 | Pre-eclampsia and risk of dementia later in life: nationwide cohort study |
| Q40283154 | Preeclampsia and cognitive impairment later in life |
| Q36965155 | Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines |
| Q95643409 | Pregnancy Outcomes and Documentation Status Among Latina Women: A Systematic Review |
| Q33427889 | Qualitative Analysis of Diagnostic Value of 24-h Proteinuria for Preeclampsia |
| Q92071252 | Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy |
| Q89089691 | Risk of cardiovascular disease, end-stage renal disease, and stroke in postpartum women and their fetuses after a hypertensive pregnancy |
| Q92701772 | Role of Circular RNAs in Preeclampsia |
| Q90254832 | Role of Mitochondrial Dysfunction and Reactive Oxygen Species in Mediating Hypertension in the Reduced Uterine Perfusion Pressure Rat Model of Preeclampsia |
| Q39107964 | Sex differences in stroke across the lifespan: The role of T lymphocytes |
| Q33434358 | The burden of maternal morbidity and mortality attributable to hypertensive disorders in pregnancy: a prospective cohort study from Uganda |
| Q57150158 | The role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia |
| Q60049523 | The umbilical cord, preeclampsia and the VEGF family |
| Q34682703 | Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review |
Search more.